Company Overview of Talima Therapeutics, Inc.
Talima Therapeutics, Inc., a specialty pharmaceutical company, engages in the development and commercialization of site-specific drug delivery systems. Its product under clinical testing is a micro implant that delivers a broad-acting small molecule to the site of infection for the treatment of onychomycosis, a fungal disease of the nails. The company was founded in 2004 and is based in Santa Clara, California.
2255 Martin Avenue
Santa Clara, CA 95050
Founded in 2004
Key Executives for Talima Therapeutics, Inc.
Similar Private Companies By Industry
|Chiron Viagene, Inc.||United States|
|BD Technologies LLC||United States|
|DelSite Biotechnologies Inc.||United States|
|Adenios, Inc.||United States|
|BioGenerics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- New York City, NY | BloombergPosted: Apr 14
- Delaware | DuPontPosted: Apr 11
- Gaithersburg, MD | MedimmunePosted: Apr 16
- New York | Shore ConsultantsPosted: Apr 14
Sponsored Financial Commentaries
To contact Talima Therapeutics, Inc., please visit www.talima.com. Company data is provided by Capital IQ. Please use this form to report any data issues.